Literature DB >> 17305492

Identification of a novel intestinal first pass metabolic pathway: NQO1 mediated quinone reduction and subsequent glucuronidation.

Haiping Hao1, Guangji Wang, Nan Cui, Jing Li, Lin Xie, Zuoqi Ding.   

Abstract

Quinones represent a very important class of compounds found in nature and for the chemically synthesized drugs. The present study was designed to elucidate the intestinal first pass metabolic pathways in vivo and in vitro, of tanshinone IIA (TS), a derivative of phenanthrene-quinone isolated from Salvia miltiorrhiza. Five metabolites, proposed to be TS catechol glucuronides (two position isomers), dehydrotanshinone IIA and its two catechol glucuronides, were identified from the rat intestinal homogenates after oral administration of TS. TS metabolism was further conducted in the subcellular system including cytosol, microsomes, mitochondrial and S9 under both phase I and phase II metabolic conditions. TS underwent negligible metabolism in all of the subcellular systems under phase I metabolic condition using NADPH as the cofactor. However, significant and substantial metabolic elimination of TS was observed in the cytosol and S9 fractions, while not in the microsomes fractions, when both NADPH and UDPGA were added. Two TS catechol glucuronides were identified from such an in vitro metabolic medium. Dicoumarol, a specific inhibitor of the NAD(P)H dependent quinone oxidoreductase (NQO1), significantly inhibited the metabolic elimination of TS in a noncompetitive way, suggesting that NQO1 was responsible for the quinone reduction of TS to form the catechol intermediate. The catechol intermediate failed to be detected directly was proved to be highly unstable and autoxidized back to TS accompanied with hydrogen peroxide generation. Dicoumarol exhibited a significant inhibitory effect on the hydrogen peroxide generation, further supporting that the reduction of TS was catalyzed by NQO1. The absolute bioavailability of TS was significantly enhanced by oral dicoumarol pretreatment. In conclusion, a novel intestinal metabolic pathway for quinones, NQO1 mediated reduction and subsequent glucuronidation, was determined using TS as a model compound. This study should be helpful for the general understanding of quinones absorption and intestinal first pass metabolism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17305492     DOI: 10.2174/138920007779816011

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  10 in total

Review 1.  The anti-Leishmania potential of bioactive compounds derived from naphthoquinones and their possible applications. A systematic review of animal studies.

Authors:  Áquila Carolina Fernandes Herculano Ramos-Milaré; Jully Oyama; Letícia Sayuri Murase; João Vítor Perez Souza; Bárbara Silva Guedes; Daniele Stéfanie Sara Lopes Lera-Nonose; Mariana Terron Monich; Aline Ávila Brustolin; Izabel Galhardo Demarchi; Jorge Juarez Vieira Teixeira; Maria Valdrinez Campana Lonardoni
Journal:  Parasitol Res       Date:  2022-02-22       Impact factor: 2.289

2.  Preclinical Pharmacokinetic Evaluation of β-Lapachone: Characteristics of Oral Bioavailability and First-Pass Metabolism in Rats.

Authors:  Iksoo Kim; Hyeongmin Kim; Jieun Ro; Kanghee Jo; Sandeep Karki; Prakash Khadka; Gyiae Yun; Jaehwi Lee
Journal:  Biomol Ther (Seoul)       Date:  2015-05-01       Impact factor: 4.634

3.  Liver-target nanotechnology facilitates berberine to ameliorate cardio-metabolic diseases.

Authors:  Hui-Hui Guo; Chen-Lin Feng; Wen-Xuan Zhang; Zhi-Gang Luo; Hong-Juan Zhang; Ting-Ting Zhang; Chen Ma; Yun Zhan; Rui Li; Song Wu; Zeper Abliz; Cong Li; Xiao-Lin Li; Xiao-Lei Ma; Lu-Lu Wang; Wen-Sheng Zheng; Yan-Xing Han; Jian-Dong Jiang
Journal:  Nat Commun       Date:  2019-04-30       Impact factor: 14.919

4.  Preparation and characterisation of solid dispersions of tanshinone IIA, cryptotanshinone and total tanshinones.

Authors:  Xifeng Zhai; Chunguang Li; George Binh Lenon; Charlie C L Xue; Weize Li
Journal:  Asian J Pharm Sci       Date:  2016-08-31       Impact factor: 6.598

5.  Molecular Mechanism of Salvia miltiorrhiza Bunge in Treating Cerebral Infarction.

Authors:  Xietao Ye; Jiali Liu; Xinyao Yuan; Songhong Yang; Yi Huang; Yan Chen
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-29       Impact factor: 2.629

6.  Glucuronidation of [6]-shogaol, [8]-shogaol and [10]-shogaol by human tissues and expressed UGT enzymes: identification of UGT2B7 as the major contributor.

Authors:  Liangliang He; Jinjin Xu; Qi Wang; Yezi Zhang; Zifei Qin; Yang Yu; Zhengming Qian; Zhihong Yao; Xinsheng Yao
Journal:  RSC Adv       Date:  2018-12-12       Impact factor: 4.036

7.  An NQO1-initiated and p53-independent apoptotic pathway determines the anti-tumor effect of tanshinone IIA against non-small cell lung cancer.

Authors:  Fang Liu; Guo Yu; Guangji Wang; Huiying Liu; Xiaolan Wu; Qiong Wang; Miao Liu; Ke Liao; Mengqiu Wu; Xuefang Cheng; Haiping Hao
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

8.  UDP-glucuronosyltransferase 1A compromises intracellular accumulation and anti-cancer effect of tanshinone IIA in human colon cancer cells.

Authors:  Miao Liu; Qiong Wang; Fang Liu; Xuefang Cheng; Xiaolan Wu; Hong Wang; Mengqiu Wu; Ying Ma; Guangji Wang; Haiping Hao
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

9.  Enhanced dissolution and stability of Tanshinone IIA base by solid dispersion system with nano-hydroxyapatite.

Authors:  Yan-Rong Jiang; Zhen-Hai Zhang; Sai-Yan Huang; Yan Lu; Tian-Tian Ma; Xiao-Bin Jia
Journal:  Pharmacogn Mag       Date:  2014-07       Impact factor: 1.085

10.  Activation of NQO1 in NQO1*2 polymorphic human leukemic HL-60 cells by diet-derived sulforaphane.

Authors:  Joseph M Wu; Ardalan Oraee; Barbara B Doonan; John T Pinto; Tze-Chen Hsieh
Journal:  Exp Hematol Oncol       Date:  2016-09-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.